Charles Gaulin

A Quality Project to Optimize Palliative Care Consultations in the Medical Intensive Care Unit

J. Shapiro, J. Fung, Charles Gaulin, 2019, Journal of Scientific Innovation in Medicine.

Routine clinical parameters and laboratory testing predict therapy-related myeloid neoplasms after treatment for breast cancer

M. Robson, E. Stein, R. Parameswaran, 2022, Haematologica.

Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm

K. Kelemen, Cecilia Arana Yi, Charles Gaulin, 2022, Life.

Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy

M. Mrugala, Shannon P. Fortin Ensign, A. Rosenthal, 2022, Current treatment options in oncology.

Hypofibrinogenemia and disseminated intravascular coagulation rarely complicate treatment-naïve acute lymphoblastic leukemia

M. Geyer, M. Tallman, A. Derkach, 2020, Leukemia & lymphoma.

Advances in the Treatment of Hairy Cell Leukemia Variant

M. Tallman, Charles Gaulin, Julie Tran, 2022, Current Treatment Options in Oncology.

Quality of life in non‐melanoma skin cancer

P. Fernández-Peñas, D. Sebaratnam, Charles Gaulin, 2015, The Australasian journal of dermatology.

Patient Reported Outcomes in Metastatic Breast Cancer Studies: Evaluating the Impact of the FDA Guidance for Industry

Charles Gaulin, G. Osorio, 2019, Journal of Scientific Innovation in Medicine.

Fungal Infections Associated with CD19-Targeted Chimeric Antigen Receptor T Cell Therapy

M. Shah, Yucai Wang, J. Blair, 2023, Current Fungal Infection Reports.